The CCK8 assay demonstrated that compared to free GEM, the proliferation-inhibiting effect of GEM-HSA-NP on MDR1- and MRP1-overexpressing pancreatic cancer cells remained potent. The gene discussed is ABCC1; the disease is familial pancreatic carcinoma.